Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients - Related Studies

Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients

This study is ongoing, but not recruiting participants.

Study NCT00001650. Last updated on July 23, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infection
		Acquired Immunodeficiency Syndrome

2	Additional conditions recognized in this trial
		HIV Infections
		Immunologic Deficiency Syndromes
		Infection
		Syndrome

3	More general conditions related to this trial
		Disease
		Immune System Diseases
		Lentivirus Infections
		Pathologic Processes
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Additional drug interventions recognized in this trial
		Bromodeoxyuridine

5	More general drug interventions related to this trial
		Anti-Infective Agents
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antiviral Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Allergy and Infectious Diseases (NIAID)